Efficacy of alemtuzumab in relapsing remitting multiple sclerosis (RRMS) patients with highly active disease despite therapy

Category Primary study
JournalEuropean Journal of Neurology
Year 2012
This article has no abstract
Epistemonikos ID: a9f140d613d6f06d79b46e89d2ab25b490a3b257
First added on: Aug 10, 2018